Clinical Trial Update: Study of Safety and Efficacy of Diractin® for the Treatment of Osteoarthritis (OA) of the Knee [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the safety and efficacy of Diractin for osteoarthritis of the knee has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• Diractin (Ketoprofen)

Snippet

Sponsor: IDEA AG | Conditions: Osteoarthritis of the Knee | Phase 3 | Status: COMPLETED